Newsletter Anmeldung

Newsletter Subscription

SAVE THE DATE: EFIB 2022 goes to Vilnius, Lithuania

EuropaBio is pleased to announce that the next edition of EFIB, Europe’s Leading Event on Industrial Biotechnology and the Bioeconomy under the title ‘Next generation economies: Industrial biotechnology for a sustainable society’, will take place 26-27 October 2022 in Vilnius, Lithuania. The Forum will be hosted by the Lithuanian Biotechnology Association (LBTA) together with Go Vilnius – the city’s official business and tourism development agency.

Now in its 15th year, EFIB will be dedicated to the innovation and commercial delivery of industrial biotechnology and the bioeconomy. EFIB will include a pre-conference science symposium ’’Gene Editing – From Research To Industry’’, followed by two day Forum discussing how Industrial biotechnology contributes to transforming sectors and addresses consumer choices and needs.

After a successful 2021 in person edition, which discussed how our companies can help to deliver the EU Green Deal, we are exploring how industrial biotechnology advances contribute to the next generation economies and creating more sustainable societies. Lithuania is an outstanding location and a growing hotspot for Life Sciences in Europe, which makes it a perfect destination for our community to gather together and search for new synergies.’ said Dr Claire Skentelbery, Director General of EuropaBio.

The conference will network and showcase more than 500 delegates from the industry of all sizes, from start-ups with the next transformative technology to multi-national producers scaling up to meet global demand for sustainable and novel products across sectors. It will also bring together the community that enables the industry to deliver, including the researchers, policy makers, academia, regulators, global organisations and local leaders that build the framework for a sustainable society.

Further information.

 

 

 

 

  26.10. – 27.10.2022
  Vilnius, Lithuania
  Further information
  Programm
  Contact